These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 20437036

  • 21. [Bisphosphonate-associated osteonecrosis of the jaw].
    Abu-Id MH, Açil Y, Gottschalk J, Kreusch T.
    Mund Kiefer Gesichtschir; 2006 Mar; 10(2):73-81. PubMed ID: 16456688
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
    Abu-Id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Acil Y, Russo PA, Kreusch T.
    J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.
    Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S.
    Osteoporos Int; 2007 Oct; 18(10):1363-70. PubMed ID: 17598065
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.
    Kang B, Cheong S, Chaichanasakul T, Bezouglaia O, Atti E, Dry SM, Pirih FQ, Aghaloo TL, Tetradis S.
    J Bone Miner Res; 2013 Jul; 28(7):1631-40. PubMed ID: 23426919
    [Abstract] [Full Text] [Related]

  • 28. Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN.
    Barasch A, Cunha-Cruz J, Curro FA, Hujoel P, Sung AH, Vena D, Voinea-Griffin AE, CONDOR Collaborative Group, Beadnell S, Craig RG, DeRouen T, Desaranayake A, Gilbert A, Gilbert GH, Goldberg K, Hauley R, Hashimoto M, Holmes J, Latzke B, Leroux B, Lindblad A, Richman J, Safford M, Ship J, Thompson VP, Williams OD, Yin W.
    J Dent Res; 2011 Apr; 90(4):439-44. PubMed ID: 21317246
    [Abstract] [Full Text] [Related]

  • 29. Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid.
    Cetiner S, Sucak GT, Kahraman SA, Aki SZ, Kocakahyaoglu B, Gultekin SE, Cetiner M, Haznedar R.
    J Bone Miner Metab; 2009 Apr; 27(4):435-43. PubMed ID: 19240969
    [Abstract] [Full Text] [Related]

  • 30. Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients.
    Owosho AA, Blanchard A, Levi L, Kadempour A, Rosenberg H, Yom SK, Farooki A, Fornier M, Huryn JM, Estilo CL.
    J Craniomaxillofac Surg; 2016 Mar; 44(3):265-70. PubMed ID: 26782845
    [Abstract] [Full Text] [Related]

  • 31. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R, Need A, Hughes T, Goss A.
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [Abstract] [Full Text] [Related]

  • 32. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.
    Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas I, Koloutsos GE, Teleioudis Z, Kitikidou K, Paraskevopoulos P, Zervas K, Antoniades K.
    J Clin Oncol; 2009 Nov 10; 27(32):5356-62. PubMed ID: 19805682
    [Abstract] [Full Text] [Related]

  • 33. Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: report of 2 cases.
    Lee JJ, Cheng SJ, Wang YP, Jeng JH, Chiang CP, Kok SH.
    Head Neck; 2013 Jan 10; 35(1):E6-10. PubMed ID: 21523843
    [Abstract] [Full Text] [Related]

  • 34. Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
    Hoefert S, Schmitz I, Tannapfel A, Eufinger H.
    Clin Oral Investig; 2010 Jun 10; 14(3):271-84. PubMed ID: 19536569
    [Abstract] [Full Text] [Related]

  • 35. Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
    Carmagnola D, Celestino S, Abati S.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec 10; 106(6):e10-5. PubMed ID: 18801674
    [Abstract] [Full Text] [Related]

  • 36. Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer.
    Van Poznak CH, Unger JM, Darke AK, Moinpour C, Bagramian RA, Schubert MM, Hansen LK, Floyd JD, Dakhil SR, Lew DL, Wade JL, Fisch MJ, Henry NL, Hershman DL, Gralow J.
    JAMA Oncol; 2021 Feb 01; 7(2):246-254. PubMed ID: 33331905
    [Abstract] [Full Text] [Related]

  • 37. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.
    Eur Urol; 2008 Nov 01; 54(5):1066-72. PubMed ID: 18602738
    [Abstract] [Full Text] [Related]

  • 38. [Osteonecrosis of the jaw and bisphophonates in oncology].
    Facon T, Bensadoun RJ, Blanc JL, Confavreux C, Gourmet R, Maes JM, Penel G, Vieillard MH, Woeller A.
    Bull Cancer; 2008 Apr 01; 95(4):413-8. PubMed ID: 18495570
    [Abstract] [Full Text] [Related]

  • 39. Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel.
    Miyazaki H, Nishimatsu H, Kume H, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Ishikawa A, Igawa Y, Hirano Y, Homma Y.
    BJU Int; 2012 Dec 01; 110(11 Pt B):E520-5. PubMed ID: 22578070
    [Abstract] [Full Text] [Related]

  • 40. Bisphosphonate-related osteonecrosis of the jaws (ONJ): a report of two cases.
    Pongchaiyakul C, Auraiwan K, Kotruchin P, Kularbkaew C.
    J Med Assoc Thai; 2007 Nov 01; 90(11):2494-8. PubMed ID: 18181340
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.